We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · August 10, 2022

Recombinant Human Endostatin Plus Whole-Brain Radiation Therapy for Brain Metastasis From NSCLC

Radiotherapy & Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Radiotherapy & Oncology
Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer
Radiother Oncol 2022 Jul 03;174(September 2022)44-51, L Chen, F Tong, L Peng, Y Huang, P Yin, Y Feng, S Cheng, J Wang, X Dong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading